📰 Section Chief News
Page 5 - Section Chief News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Section Chief. Real-time updates on events, politics, business and more.
January 5, 2024
“All of the persons who were in positions of trust for these thousand plus nursing students failed them,” said attorney David Slossberg.
January 4, 2024
Robotic surgery offers significant benefits over laparoscopic procedures for many patients undergoing colectomies for colon cancer, according to a study by UT S
January 4, 2024
Robotic surgery offers significant benefits over laparoscopic procedures for many patients undergoing colectomies for colon cancer, according to a study by UT S
January 3, 2024
Children’s Hospital Los Angeles has performed its 500th liver transplant—a milestone achievement that only a handful of pediatric centers in the country hav
December 24, 2023
House Judiciary Committee Chairman Congressman Jim Jordan (R-Ohio) plans to question Hunter Biden’s former prosecutor about the handling of the
December 15, 2023
/PRNewswire/ -- The Metal Industries Research & Development Centre (MIRDC) and ECM Group jointly announced the establishment of the Asia-Pacific Vacuum Heat...
December 14, 2023
BRAINTREE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has entered into a collaboration
December 12, 2023
This Week in Washington: House Energy and Commerce Committee markup includes 19 healthcare bills; Senate HELP Committee to mark up SUPPORT Act Reauthorization and three other bills;...
December 11, 2023
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of sickle cell disease (SCD) in patients ...
December 11, 2023
BOSTON - Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced today that the U.S. Food and Drug Administration has approved CASGEVY , a CRISPR/Cas9 genome-edited cell therapy, for...